Cite

HARVARD Citation

    Eisemann, T. et al. (2019). Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma. Neuro-oncology. 21 (3), pp. 326-336. [Online]. 
  
Back to record